Triple-negative breast cancer incidence in the United States: ecological correlations with area-level sociodemographics, healthcare, and health behaviors
- PMID: 32671723
- PMCID: PMC7796916
- DOI: 10.1007/s12282-020-01132-w
Triple-negative breast cancer incidence in the United States: ecological correlations with area-level sociodemographics, healthcare, and health behaviors
Abstract
Purpose: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer, more commonly diagnosed among black women than other subgroups. TNBC varies geographically, but little is known about area-level characteristics associated with elevated incidence.
Methods: We generated 2011-2013 age-adjusted TNBC incidence rates for state economic areas (SEAs) in 43 states using data from North American Association of Central Cancer Registries. For cases missing data on molecular markers, we imputed TNBC status using cross-marginal proportions. We linked these data to SEA covariates from national sources. Using linear ecological regression, we examined correlates of TNBC incidence rates for the overall population and for age (< 50 years or 50 + years)- or race (white or black)-specific subgroups.
Results: The mean annual incidence of TNBC across SEAs was 13.7 per 100,000 women (range = 4.5-26.3), with especially high and variable rates among African American women (mean = 20.5, range 0.0-155.1). TNBC incidence was highest in South Atlantic and East South Central Census Divisions and lowest in Mountain Division. Overall TNBC incidence was associated with SEA sociodemographics (e.g., percent of females age 45 + who are non-Hispanic black: coefficient estimate [est.] = 1.62), healthcare characteristics (e.g., percent of population without health insurance: est. = - 0.52), and health behaviors (e.g., prevalence of obesity among women: est. = 0.72) (all p < 0.05). Other variables related to TNBC incidence included density of obstetrician/gynecologists and prevalence of smoking.
Conclusion: TNBC incidence varied across SEAs in the U.S., particularly for African American women. Identifying areas with elevated TNBC incidence can facilitate research and interventions on area- and individual-level correlates of TNBC.
Keywords: Geographic disparities; Health behaviors; Healthcare; Sociodemographics; Triple-negative breast cancer.
Conflict of interest statement
Figures



Similar articles
-
State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer Among US Women.JAMA Oncol. 2023 May 1;9(5):700-704. doi: 10.1001/jamaoncol.2022.7835. JAMA Oncol. 2023. PMID: 36862439 Free PMC article.
-
Racial and regional disparities of triple negative breast cancer incidence rates in the United States: An analysis of 2011-2019 NPCR and SEER incidence data.Front Public Health. 2022 Dec 1;10:1058722. doi: 10.3389/fpubh.2022.1058722. eCollection 2022. Front Public Health. 2022. PMID: 36530732 Free PMC article.
-
Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database.Medicine (Baltimore). 2016 Aug;95(35):e4614. doi: 10.1097/MD.0000000000004614. Medicine (Baltimore). 2016. PMID: 27583878 Free PMC article.
-
Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors.Front Public Health. 2020 Dec 22;8:576964. doi: 10.3389/fpubh.2020.576964. eCollection 2020. Front Public Health. 2020. PMID: 33415093 Free PMC article. Review.
-
Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review.JAMA Surg. 2017 May 1;152(5):485-493. doi: 10.1001/jamasurg.2017.0005. JAMA Surg. 2017. PMID: 28355428 Review.
Cited by
-
Risk factors and survival of triple-negative breast cancer among breast cancer patients: Ten-year cross-sectional study in the southwestern Iranian population.Health Sci Rep. 2023 Dec 17;6(12):e1767. doi: 10.1002/hsr2.1767. eCollection 2023 Dec. Health Sci Rep. 2023. PMID: 38111745 Free PMC article.
-
Anticancer activity of luteolin glycosides.EXCLI J. 2020 Aug 14;19:1154-1155. doi: 10.17179/excli2020-2747. eCollection 2020. EXCLI J. 2020. PMID: 33088251 Free PMC article. No abstract available.
-
The role of area-level socioeconomic disadvantage in racial disparities in cancer incidence in metropolitan Detroit.Cancer Med. 2023 Jul;12(13):14623-14635. doi: 10.1002/cam4.6065. Epub 2023 May 15. Cancer Med. 2023. PMID: 37184135 Free PMC article.
-
Racial disparities in triple negative breast cancer: toward a causal architecture approach.Breast Cancer Res. 2022 Jun 1;24(1):37. doi: 10.1186/s13058-022-01533-z. Breast Cancer Res. 2022. PMID: 35650633 Free PMC article.
-
Assessing Real-World Racial Differences Among Patients With Metastatic Triple-Negative Breast Cancer in US Community Practices.Front Public Health. 2022 May 24;10:859113. doi: 10.3389/fpubh.2022.859113. eCollection 2022. Front Public Health. 2022. PMID: 35685754 Free PMC article.
References
-
- National Cancer Institute. Cancer stat facts: Female breast cancer. 2018; https://seer.cancer.gov/statfacts/html/breast.html, 2018.
-
- Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype. Cancer. 2007;109(9):1721–1728. - PubMed
-
- Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. Jama. 2006;295(21):2492–2502. - PubMed
-
- Dawood S. Triple-negative breast cancer. Drugs. 2010;70(17):2247–2258. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials